16th Sep 2020 14:01
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) | Barclays PLC. | |
Company dealt in | WILLIS TOWERS WATSON PLC | |
Class of relevant security to which the | ORD | |
dealings being disclosed relate (Note 2) | ||
Date of dealing | 15 September 2020 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Class of relevant security: | ORD | ||||
Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities | ||||
2,208,717 | 1.71% | 466,648 | 0.36% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
587,000 | 0.46% | 388,524 | 0.30% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
|
|
|
| ||
TOTAL: |
|
|
|
| |
2,795,717 | 2.17% | 855,172 | 0.66% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
|
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 4 | 206.3400 USD |
Purchase | 30 | 207.4600 USD |
Purchase | 100 | 206.4400 USD |
Purchase | 100 | 205.9600 USD |
Purchase | 146 | 206.5224 USD |
Purchase | 152 | 207.6798 USD |
Purchase | 170 | 207.4905 USD |
Purchase | 200 | 207.7012 USD |
Purchase | 208 | 207.5521 USD |
Purchase | 297 | 207.6137 USD |
Purchase | 300 | 206.9416 USD |
Purchase | 300 | 207.9400 USD |
Purchase | 400 | 207.3050 USD |
Purchase | 420 | 207.8602 USD |
Purchase | 425 | 207.4477 USD |
Purchase | 970 | 207.7312 USD |
Purchase | 1,497 | 206.2984 USD |
Purchase | 2,190 | 207.2173 USD |
Purchase | 2,400 | 207.8293 USD |
Purchase | 3,701 | 206.2500 USD |
Purchase | 4,003 | 207.1525 USD |
Purchase | 7,759 | 206.7429 USD |
Purchase | 8,827 | 207.2995 USD |
Purchase | 10,339 | 206.9060 USD |
Purchase | 99,800 | 207.1234 USD |
Sale | 1 | 207.9900 USD |
Sale | 2 | 208.0150 USD |
Sale | 2 | 207.8550 USD |
Sale | 4 | 206.3400 USD |
Sale | 4 | 207.9512 USD |
Sale | 5 | 207.5900 USD |
Sale | 5 | 207.8320 USD |
Sale | 9 | 207.8444 USD |
Sale | 10 | 207.4440 USD |
Sale | 11 | 206.6500 USD |
Sale | 17 | 207.4750 USD |
Sale | 21 | 207.7573 USD |
Sale | 29 | 207.4700 USD |
Sale | 76 | 207.6798 USD |
Sale | 100 | 207.9500 USD |
Sale | 100 | 206.9700 USD |
Sale | 200 | 207.2350 USD |
Sale | 285 | 206.7756 USD |
Sale | 300 | 208.0441 USD |
Sale | 303 | 207.0021 USD |
Sale | 350 | 206.3671 USD |
Sale | 500 | 207.7810 USD |
Sale | 516 | 206.3383 USD |
Sale | 927 | 207.3341 USD |
Sale | 1,400 | 206.8357 USD |
Sale | 1,497 | 206.2984 USD |
Sale | 1,900 | 207.2255 USD |
Sale | 1,900 | 207.8421 USD |
Sale | 2,187 | 206.1725 USD |
Sale | 3,779 | 206.2500 USD |
Sale | 3,900 | 207.1641 USD |
Sale | 4,212 | 206.6353 USD |
Sale | 4,235 | 207.0072 USD |
Sale | 4,277 | 206.9685 USD |
Sale | 5,142 | 207.5274 USD |
Sale | 5,200 | 207.0489 USD |
Sale | 7,738 | 207.2026 USD |
Sale | 7,876 | 207.3083 USD |
Sale | 7,954 | 207.1910 USD |
Sale | 8,286 | 207.5730 USD |
Sale | 9,039 | 206.8860 USD |
Sale | 10,569 | 206.8754 USD |
Sale | 44,842 | 207.0666 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing |
and any other person relating to the voting rights of any relevant securities under any option |
referred to on this form or relating to the voting rights or future acquisition or disposal of any |
relevant securities to which any derivative referred to on this form is referenced. If none, this |
should be stated. |
NONE |
Is a Supplemental Form 8 (Open Positions) attached? | NO |
Date of disclosure: | 16 Sep 2020 |
Contact name: | Large Holdings Regulatory Operations |
Telephone number: | 020 3134 7213 |
If a connected EFM, name of offeree/offeror with which connected | |
If a connected EFM, state nature of connection |
View source version on businesswire.com: https://www.businesswire.com/news/home/20200916005566/en/
Copyright Business Wire 2020
Related Shares:
Barclays